BiomX Inc. insider trading

PHGENYSE

$0.41+0.05 (+13.89% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-99.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Unlock quarterly net flow

Key players

CFCystic Fibrosis Foundation10% Owner0.0035%of company
JEJonathan Eitan SolomonChief Executive Officer0.0025%of company
MBMerav BassanChief Development Officer0.0016%of company
MWMarina WolfsonChief Financial Officer0.0014%of company
RYReuven YeganehDirector0.00%of company
DMDeerfield Management CoDirectorNot reportedof company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
PHGE	Reuven YeganehDirector	Open market sell$2.65M	-100.0%	$5.00	$2.65M	Mar 17, 2026	Mar 18, 2026
PHGE	Reuven YeganehDirector	Open market sell$2.25M	-100.0%	$5.00	$2.25M	Mar 16, 2026	Mar 18, 2026
PHGE	Reuven YeganehDirector	Open market sell$1.85M	-100.0%	$5.00	$1.85M	Mar 13, 2026	Mar 13, 2026
PHGE	Reuven YeganehDirector	Open market sell$1.5M	-100.0%	$5.00	$1.5M	Mar 12, 2026	Mar 13, 2026

End of history · 4 transactions